Titre:
  • Adjuvant Anti-HER2 Therapy, Treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early Breast Cancer Patients.
Auteur:Lambertini, Matteo; Campbell, Christine; Bines, Jose; Korde, Larissa A; Izquierdo, Miguel; Fumagalli, Debora; Del Mastro, Lucia; Ignatiadis, Michail; Pritchard, Kathleen; Wolff, Antonio C; Jackisch, Christian; Lang, Istvan; Untch, Michael; Smith, Ian; Boyle, Frances; Xu, Binghe; Barrios, Carlos H; Baselga, José; Moreno-Aspitia, Alvaro; Piccart-Gebhart, Martine; Gelber, Richard D; De Azambuja, Evandro
Informations sur la publication:Journal of the National Cancer Institute
Statut de publication:Publié, 2018-06
Sujet CREF:Cancérologie
Médecine pathologie humaine
Sciences bio-médicales et agricoles
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0027-8874
info:doi/10.1093/jnci/djy094
info:pii/5033460
info:scp/85059873068
info:pmid/29878225
PMC6335113